A Dual-Ion Synergistic Catalysis Utilizing Zn-Regulated CdSSe ECL Immunosensor Employed for the Ultrasensitive CA19-9 Detection.
Carbohydrate antigen 19-9 is a well-known malignancy biomarker, and its sensitive detection is particularly crucial in the diagnosis and assessment of pancreatic cancer.
APA
Fan D, Gong Z, et al. (2024). A Dual-Ion Synergistic Catalysis Utilizing Zn-Regulated CdSSe ECL Immunosensor Employed for the Ultrasensitive CA19-9 Detection.. Analytical chemistry, 96(49), 19750-19757. https://doi.org/10.1021/acs.analchem.4c05034
MLA
Fan D, et al.. "A Dual-Ion Synergistic Catalysis Utilizing Zn-Regulated CdSSe ECL Immunosensor Employed for the Ultrasensitive CA19-9 Detection.." Analytical chemistry, vol. 96, no. 49, 2024, pp. 19750-19757.
PMID
39572396
Abstract
Carbohydrate antigen 19-9 is a well-known malignancy biomarker, and its sensitive detection is particularly crucial in the diagnosis and assessment of pancreatic cancer. In this study, an ultrasensitive CA19-9 immunosensor was constructed using the Zn-regulated CdSSe (Zn-CdSSe) nanospheres (NSs) as the electrochemiluminescence (ECL) emitter and FeCoS nano octahedrons (NOs) as a coreactant enhancer. The microstructure of ternary transition metal chalcogenide CdSSe was precisely tuned by Zn doping to avoid aggregation and thus enable stable and efficient cathodic ECL responses. The bimetallic sulfide FeCoS was synthesized using a metal organic framework (MOF) as the template by ion permeation. It was able to catalyze the coreactant efficiently due to the synergistic effect of the Fe and Co. The immunosensor exhibited low detection limit (7.6 × 10 U mL) in the wide linear range of 0.0001-100 U mL, offering a sensitive CA19-9 detection method.
MeSH Terms
Zinc; Humans; Electrochemical Techniques; Luminescent Measurements; Catalysis; Immunoassay; CA-19-9 Antigen; Limit of Detection; Cadmium Compounds; Biosensing Techniques; Sulfides; Nanospheres
같은 제1저자의 인용 많은 논문 (4)
- Coagulation parameters in gastrointestinal cancer patients with venous thromboembolism.
- [Erianin inhibits proliferation and migration of breast cancer cells by inhibiting Wnt/β-catenin signaling].
- Boosting Hydroxyl Migration over Palladium-Based Catalysts to Enhance the Alkaline Hydrogen Oxidation.
- Downregulation of MUC1 Enhances Antitumor Response in Colon Cancer Model by Decreasing PD-L1 Expression In Vivo and In Vitro.